11.00
0.38 (3.53%)
| Previous Close | 10.63 |
| Open | 10.44 |
| Volume | 139,323 |
| Avg. Volume (3M) | 269,735 |
| Market Cap | 35,974,400 |
| Price / Sales | 4.35 |
| Price / Book | 7.29 |
| 52 Weeks Range | |
| Earnings Date | 14 Aug 2024 |
| Profit Margin | -33.78% |
| Operating Margin (TTM) | -30.13% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | -22.20% |
| Total Debt/Equity (MRQ) | 7.14% |
| Current Ratio (MRQ) | 1.43 |
| Levered Free Cash Flow (TTM) | -3.01 M |
| Return on Assets (TTM) | -13.51% |
| Return on Equity (TTM) | -36.19% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (GB) | Mixed | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | INTELLIGENT ULTRASOUND GROUP PL | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 0.0 |
| Average | 0.00 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| INTELLIGENT ULTRASOUND GROUP PL | 36 M | - | - | 7.29 |
| 0K5E | 765 M | 4.01% | 7.06 | - |
| MAXCYTE INC COM STK USD0.01 (DI | 202 M | - | - | 1.43 |
| CREO MEDICAL GROUP PLC ORD GBP0 | 44 M | - | - | 1.57 |
| NOVACYT S.A. EUR1/15TH (CDI) | 34 M | - | - | 0.710 |
| INSPIRATION HEALTHCARE GROUP PL | 15 M | - | - | 0.550 |
|
Intelligent Ultrasound Group PLC is engaged in the development, marketing, and distribution of ultrasound simulation devices for use in the training of medical professionals. Its product categories ScanTrainer; HeartWorks; BodyWorks; and ORSIM Bronchoscopy Simulator. The Company has two reportable segments such as Simulation which involves sales of ultrasound simulation systems and related services, and Clinical AI which is involved in sales of AI-related ultrasound image analysis software products. The company earns the majority of its revenue from the Simulation segment. Geographically, it has a presence in the United Kingdom, North America, and the Rest of the World. It derives the maximum of its revenue from the Rest of the World. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 12.70% |
| % Held by Institutions | 88.38% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |